Clark Capital Management Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6M | Buy |
666,513
+275,344
| +70% | +$19.2M | 0.32% | 113 |
|
|
2025
Q1 | $28.8M | Buy |
391,169
+381,122
| +3,793% | +$28M | 0.21% | 133 |
|
|
2024
Q4 | $658K | Buy |
10,047
+4,738
| +89% | +$310K | ﹤0.01% | 323 |
|
|
2024
Q3 | $414K | Sell |
5,309
-135
| -2% | -$10.5K | ﹤0.01% | 341 |
|
|
2024
Q2 | $425K | Buy |
5,444
+296
| +6% | +$23.1K | ﹤0.01% | 324 |
|
|
2024
Q1 | $349K | Sell |
5,148
-427
| -8% | -$28.9K | ﹤0.01% | 346 |
|
|
2023
Q4 | $375K | Buy |
5,575
+448
| +9% | +$30.2K | ﹤0.01% | 331 |
|
|
2023
Q3 | $347K | Sell |
5,127
-148
| -3% | -$10K | ﹤0.01% | 302 |
|
|
2023
Q2 | $378K | Sell |
5,275
-280
| -5% | -$20K | ﹤0.01% | 305 |
|
|
2023
Q1 | $386K | Sell |
5,555
-330,991
| -98% | -$23M | ﹤0.01% | 299 |
|
|
2022
Q4 | $22.8M | Buy |
336,546
+12,130
| +4% | +$822K | 0.21% | 141 |
|
|
2022
Q3 | $17.8M | Sell |
324,416
-128,053
| -28% | -$7.02M | 0.23% | 149 |
|
|
2022
Q2 | $29.9M | Sell |
452,469
-273,552
| -38% | -$18.1M | 0.39% | 67 |
|
|
2022
Q1 | $48.2M | Buy |
726,021
+17,139
| +2% | +$1.14M | 0.54% | 40 |
|
|
2021
Q4 | $41.3M | Sell |
708,882
-582,821
| -45% | -$33.9M | 0.51% | 63 |
|
|
2021
Q3 | $77.6M | Buy |
1,291,703
+290,249
| +29% | +$17.4M | 1.06% | 16 |
|
|
2021
Q2 | $60M | Buy |
1,001,454
+367,294
| +58% | +$22M | 0.84% | 23 |
|
|
2021
Q1 | $31.5M | Sell |
634,160
-37,015
| -6% | -$1.84M | 0.48% | 75 |
|
|
2020
Q4 | $33.6M | Buy |
+671,175
| New | +$33.6M | 0.55% | 52 |
|